Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Diabetes Res ; 2020: 6762709, 2020.
Article in English | MEDLINE | ID: mdl-32626781

ABSTRACT

Diabetes mellitus (DM) is a chronic endocrine disease characterized by persistent hyperglycemia. Oxidative damage, inflammatory cytokines, and apoptotic cell death play a major role in the induction and progression of male testicular damage. Plant-derived phytochemicals such as green coffee (Coffea arabica) can possess antidiabetic effects with little toxicity. The current study is aimed at investigating the therapeutic roles of green coffee in diabetic testicular injury stimulated by high-fat diet/streptozotocin administration. Diabetes mellitus was induced by a high-fat diet and a single dose of streptozotocin (STZ) (35 mg kg-1) in male albino rats. Diabetic animals were orally given two different concentrations of green coffee (50 mg kg-1 and 100 mg kg-1) for 28 days. The levels of testosterone, luteinizing hormone, and follicle-stimulating hormone and parameters of oxidative stress, inflammation, and apoptosis were measured. mRNAs and protein levels were detected quantitatively by real-time PCR and ELISA, respectively. In the diabetic group, the levels of testosterone, luteinizing hormone, and follicle-stimulating hormone showed a significant reduction while they increased significantly after green coffee treatment. A significant increase of antioxidant markers glutathione, superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase along with decreased levels of lipid peroxides and nitric oxide was observed after green coffee treatment in the diabetic group. Finally, the levels of IL-1ß, TNF-α, Bax, and caspase-3 were also decreased in both treated groups (metformin and green coffee) when compared to the diabetic group. We conclude that testicular oxidative impairment induced by a high-fat diet (HFD) and STZ can be reversed by green coffee. Administration of green coffee could represent a promising therapeutic agent which can help the treatment of type 2 DM-induced testicular dysfunction.


Subject(s)
Apoptosis/drug effects , Coffea , Diabetes Complications/metabolism , Diabetes Mellitus, Experimental/metabolism , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Testicular Diseases/metabolism , Testis/drug effects , Animals , Caspase 3/drug effects , Caspase 3/metabolism , Catalase/drug effects , Catalase/metabolism , Diet, High-Fat , Enzyme-Linked Immunosorbent Assay , Follicle Stimulating Hormone/metabolism , Glutathione/drug effects , Glutathione/metabolism , Glutathione Peroxidase/drug effects , Glutathione Peroxidase/metabolism , Glutathione Reductase/drug effects , Glutathione Reductase/metabolism , Hypoglycemic Agents/pharmacology , Inflammation/metabolism , Interleukin-1beta/drug effects , Interleukin-1beta/metabolism , Lipid Peroxidation/drug effects , Luteinizing Hormone/drug effects , Luteinizing Hormone/metabolism , Male , Metformin/pharmacology , Nitric Oxide/metabolism , RNA, Messenger , Rats , Real-Time Polymerase Chain Reaction , Streptozocin/toxicity , Superoxide Dismutase/drug effects , Superoxide Dismutase/metabolism , Testis/metabolism , Testosterone/metabolism , Tumor Necrosis Factor-alpha/drug effects , Tumor Necrosis Factor-alpha/metabolism , bcl-2-Associated X Protein/drug effects , bcl-2-Associated X Protein/metabolism
2.
Metab Brain Dis ; 35(7): 1175-1187, 2020 10.
Article in English | MEDLINE | ID: mdl-32548708

ABSTRACT

Diabetes mellitus is an increasing metabolic disease worldwide associated with central nervous system disorders. Coffee is a widely consumed beverage that enriched with antioxidants with numerous medicinal applications. Accordingly, the present study aimed to investigate the therapeutic potential of orally administered green coffee bean water extract (GCBWE) against cortical damage induced by high fat diet (HFD) followed by a single injection of streptozotocin (STZ) in rats. Metformin (Met) was used as standard antidiabetic drug. Animals were allocated into six groups: control, GCBWE (100 mg/kg), HFD/STZ (40 mg/kg), HFD/STZ + GCBWE (50 mg/kg), HFD/STZ + GCBWE (100 mg/kg) and HFD/STZ + Met (200 mg/kg) which were treated daily for 28 days. Compared to control rats, HFD/STZ-treated rats showed decreased levels of cortical dopamine, norepinephrine and serotonin with marked increases in their metabolites. Further, HFD/STZ treatment resulted in notable elevations in malondialdehyde, protein carbonyl and total nitrite levels paralleled with declines in antioxidant markers (SOD, CAT, GPx, GR and GSH) and down-regulations of Sod2, Cat, GPx1 and Gsr gene expression. Neuroinflammation was evident in diabetic animals by marked elevations in TNF-α, IL-1ß and up-regulation of inducible nitric oxide synthase. Significant rises incaspase-3 and Bax with decline in Bcl-2 level were noticed in diabetic rats together with similar results in their gene expressions. Cortical histopathological examination supported the biochemical and molecular findings. GCBWE administration achieved noteworthy neuroprotection in diabetic animals in most assessed parameters. The overall results suggested that antioxidant, anti-inflammatory; anti-apoptotic activities of GCBWE restored the cortical neurochemistry in diabetic rats.


Subject(s)
Brain/drug effects , Coffee , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/pharmacology , Plant Extracts/pharmacology , Animals , Blood Glucose , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Dopamine/metabolism , Hypoglycemic Agents/therapeutic use , Male , Metformin/pharmacology , Metformin/therapeutic use , Norepinephrine/metabolism , Oxidative Stress/drug effects , Plant Extracts/therapeutic use , Rats , Rats, Wistar , Serotonin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL